Congress Topics

WCA-2020 GAA Interasma powered by FREI SA

Acute asthma


Causes and risk factors
Management and prevention
Lessons from Emergency Room Management of Asthma

Allergen Immunotherapy


Current standards
Oral immunotherapy update-
Role of SLIT in Asthma

Allergic Rhinitis Impact on Asthma


Shared Pathophysiology of Allergic Rhinitis and Asthma
Impact of Allergic Rhinitis Therapies in Asthma
Allergen Immunotherapy in Asthma
Sub Lingual Allergen Immunotherapy for Dust Mite in Asthma and Allergic Rhinitis
Safety of Subcutaneous versus Sublingual Immunotherapy in Asthma

Allergy


Allergy testing
Aero-allergens and airways
The ARIA initiative

Anaphylaxis


Pathophysiology
Food allergy
Venom Allergy
Drug Allergy
Treatment Paradigms for anaphylaxis

Asthma and COPD


Role of Eosinophils in ACOS
Role of Th2 inflammation in ACOS
Heterogeneity of Immune Pathogenesis of Asthma and COPD
Assessment of Benefits of New LAMAs in Asthma and COPD
ICS plus LABA plus LAMA in Asthma and COPD
Role of new Biologicals in COPD

Asthma and specific conditions and populations


Asthma and pregnancy
Asthma in the elderly
Managing Allergy & Asthma in Resource Poor Settings
War-time asthma: lessons from Syria
Asthma in children less than 5 years old
Asthma in teenagers

Asthma co-morbidities


Asthma and rhinitis
Asthma and upper airways dysfunction
Obesity and asthma
Asthma and psychological problems
The asthma-COPD Overlap
Atopic dermatitis
Chronic Rhinosinusitis and Th2 inflammation

Asthma diagnosis


Under and overtreatment of asthma
Standards for the diagnosis of asthma
Pulmonary function tests

Asthma epidemiology


Incidence and prevalence of asthma in the world
Morbidity and mortality from asthma
Lung function decline and its determinants
Age and gender differences
Natural history of asthma: can it be altered
Asthma remissions
Does the “hygiene hypothesis” still holds?

Asthma pathophysiology


Airway inflammation
Epithelial dysfunction
Airway remodelling
Neurogenic factors

Asthma phenotypes


Asthma phenotyping : practical aspects
Asthma endotyping : is it worth doing ?
Severe asthma
Occupational asthma
Asthma in the athlete
Eosinophilic asthma
Non-eosinophilic asthma
Cluster analysis of asthma phenotypes
Th17 immune responses in Asthma
Innate Lymphocyte Type 2 driven Asthma
Aspirin Exacerbated Respiratory Disease

Asthma treatment


Adherence to therapy: a major asthma management problem
Inhaler techniques
Initial treatment of asthma: when to introduce ICS ?
New inhalers
Future treatment of asthma
Non-pharmacologic asthma therapies
Efficacy of Bronchothermoplasty in Asthma
LAMA versus LABA for Asthma
Allergic Moderate to Severe Asthma Treatment Options
Impact of new Asthma Biologicals on Asthma Exacerbations and Lung Function

Atopic Dermatitis


Pathopysiology- Similarities and Differences from Asthma
The Allergic March
New Therapies- Topical
New Therapies- Biologics

Clinical aspects of asthma: the patient perspective


Perception of asthma symptoms
Patients’ expectations
Patient opinions on asthma treatment
The expert patient

Drugs for asthma and COPD


β2-agonists
Inhaled corticosteroids
Anti-cholinergics
Leukotriene antagonists
Combination therapies (double and triple combinations)
Monoclonal antibodies

Educational interventions


Asthma education and knowledge translation
Educational interventions in COPD
Motivational interview
Shared-decision making
The asthma action plan
Role of the expert-patient
Training educators

Environmental factors and asthma


Allergens
Workplace inhalants
Air pollution
Weather conditions (thunderstorms)
Climate change

Food allergy


New developments
Management
Role in Asthma
Peanut Allergy Therapeutic Approaches

GINA and GOLD 2018 update


New GINA report
New GOLD report
Asthma-COPD overlap report
GINA-GOLD Implementation program

Mast Cell Activation Syndrome


Pathophysiology
Associated Conditions
Diagnostic Criteria
Differential Diagnosis
Treatment Options

Non-invasive airway inflammation assessment


Induced sputum analysis
Exhaled NO measures

Precision medicine


Personalized medicine: how to make it happen
Biomarkers of asthma
Targeting asthma therapy
Il5 versus IgE as a Therapeutics target in Asthma
Anti-IgE
Anti-IL5
Other cytokines antagonists

Respiratory infections and asthma


Bacterial infections
Viral infections
Other agents
Influence of vaccination

Risk factors of asthma


Vitamin deficiency and nutritional factors
Smoking (direct and secondary)
Exposure to bacteria (microbiome)
Genetic factors

Severe asthma


Assessment of severe asthma
Management of difficult-to-control asthma
Severe pediatric asthma
New monoclonal antibodies
Thermoplasty update
Can we predict response to therapies
New therapies to come